Newsflashes | EqualOcean

All

May 8/ Monday

06:52 PM

QingSong Health and Volcano Engine Join Hands to Launch First AIGC Doctor-Patient Interaction App

QingSong Health (Chinese: 轻松集团·轻松健康), a leading Chinese online health insurance technology platform, joined hands with ByteDance's cloud service Volcano Engine, to implement the first AIGC-based doctor-patient interaction application. With the aim of building a comprehensive and solid "protective cover" for each family, QingSong Health has established a trusted set of whole lifecycle health management system, tackling the aging of the population. The launch of this AIGC audio and video doctor-patient interaction application will further optimize the experience of doctor-patient interaction in social security, medical care, and nursing care for elderly people. Volcano Engine provides intelligent solutions owing to ByteDance and helps with the implementation of the launch.

Apr 23/ Sunday

11:24 AM

Chinese Contact Center Solution Provider Sobot Technologies

Sobot Technologies (Chinese: 智齿科技), a Beijing-based customer service software provider, held a strategic summit on April 20 with the theme of “New Contact Makes the World Borderless” in Shenzhen. Yi Xu, co-founder and CEO of Sobot Technologies, officially launched the "3I-strategy", that is , integration, intellectualization and internationalization. The company also completed the brand upgrade with a brand new logo. Founded in 2014 and headquartered in Beijing, Sobot Technologies positioned itself as a software-as-a-service (SaaS) company, whose key offering is in-house developed customer contact solutions. Up to now, Sobot Technologies has established cooperation with OPPO, TINECO, HP, OPAY, DFS, Blued and a slew of other top clients.

Mar 31/ Friday

12:34 PM
Consumer Discretionary
BGI Genomics: Net Profit Achieves CNY 803 Mn in 2022, Down 45.06% YoY

BGI Genomics (300676:SH) disclosed its annual report on March 30, with a revenue of CNY 7.046 billion in 2022, up 4.14% year on year and a net profit of CNY 803 million, down 45.06%. Basic earnings per share (EPS) is CNY 1.96. The profit distribution plan approved by the Board of Directors is as follows: a cash dividend of CNY 10 (including tax) for every 10 shares to all shareholders based on 413,914,325 shares, a bonus of 0 shares (including tax) and an increase of 0 shares for every 10 shares to all shareholders from the capital reserve.

Consumer Discretionary

Mar 29/ Wednesday

09:33 AM

Tencent to Sale Sanook.com 100%, Sources Said

Chinese tech giant Tencent wants to sale its wholly owned subsidiary Sanook Online, a leading Thai web portal, sources said. Sanook started in 1998 as a Thai-based web directory and gradually developped into an all-inclusive entity with businesses ranging from web portal (Sanook.com), news portal (NoozUp), music-streaming (JOOX), IM (WeChat), and e-commerce (Sabuy). Previously in 2016, Tencent has branded it to Tencent (Thailand). Sanook's revenue continued to recover from THB 118 million in 2020 to THB 190 miilion in 2022, with a stable monthly-active-user (MAU) at 30 to 40 million. Moreover, the loss in the past 2022 was THB 19 miilion, due to a higher shared cost allocated to Sanook due to JOOX termination. However, 2023 is expected to be profitable, sources said.

Mar 21/ Tuesday

Mar 17/ Friday

Feb 23/ Thursday

Feb 21/ Tuesday

Feb 16/ Thursday

12:51 PM
Healthcare
Innovative Drug Developer Rezu Bio Raised CNY 10 Mn in Series Pre-A

Rezu Bio (Chinese: 宁康瑞珠) announced the close of a CNY 10 million Series Pre-A funding round, which was led by Riverhead Capital (Chinese: 阳光融汇资本). Riemann Hypothesis (Chinese: 黎曼猜想) acted as the exclusive financial adviser. Proceeds raised in this round will be mainly used in platform building and the promotion of product pipeline development. Rezu Bio has developed a brand-new colon-restricted drug design platform with completely independent intellectual property rights, which can help companies obtain multiple compounds targeting colon targets. Since designed compounds mainly act on local tissues or organs, which can avoid toxic side effects caused by systemic circulation, thereby are safer and more efficient.

Healthcare

Feb 15/ Wednesday

12:32 PM
Healthcare
ZD Medtech Raised Over CNY 100 Mn in Series B

ZD Medtech (Chinese: 卓道医疗) announced that it had completed an over CNY 100 million Series B funding round, which was co-led by Redhill Capital (Chinese: 丹麓资本) and Hengxu Capital (Chinese: 恒旭资本), followed by Shunwei Capital (Chinese: 顺为资本). Proceeds raised in this round will accelerate the process of R&D, market access, and economies of scale in smart rehabilitation solutions field. Founded in 2015, ZD Medtech is a company specializing in the development and application of rehabilitation robots and intelligent rehabilitation solutions. The rehabilitation robots developed based on systematic and multidisciplinary rehabilitation robot technology platform have been applied in nearly a thousand hospitals and institutions across the country.

Healthcare

Feb 13/ Monday

12:54 PM
Healthcare
Smart Powered Bionic Prosthetic Star BionicM Nets Over CNY 10 Mn

BionicM (Chinese: 健行仿生) has raised an over CNY 10 million financing, which was led by NEC’s subsidiary NVenture Capital, followed by Shinsei Corporate Investment, UTokyo Innovation Platform, Kiraboshi Capital, Chiba Bank Capital, AIS CAPITAL, and individual investors former Anker Japan CEO, and EPS Chairman. Proceeds will be mainly used in three aspects: firstly expand the sales of smart powered robotic prosthesis: Bio Leg and Cybo Leg, then develop the next-generation smart powered robotic prosthesis and start the research of sensor and auxiliary technology in gait, lastly accelerate the business growth and improve organizational structure. BionicM is an international smart wearable robot company dedicated to powering mobility for handicapped and non-handicapped by fusing robotics technol

Healthcare

Feb 9/ Thursday

04:13 PM

JD's REIT Debuts on STEC Raising over CNY 1.75 Bn

Harvest & JD Storage Logistics REIT (Chinese: 嘉实京东仓储物流封闭式基础设施证券投资基金, SH: 508098) debuted on the Shanghai Stock Exchange yesterday, raising CNY 1.75 billion (USD 260 million). Its price saw a huge leap of 11.64% on the first trading day, closing at CNY 3.92. Harvest & JD Storage Logistics REIT, founded on January 11, 2023, and managed by Harvest Fund (Chinese: 嘉实基金), is the first real estate investment trust in China issued by a privately owned company. Assets of the REIT include three logistics parks owned by JD in Langfang, Hebei province, Wuhan, Hubei province, and Chongqing.

Feb 8/ Wednesday

11:44 AM
Healthcare
Medical Technology Company MacroLux Nets Nearly CNY 100 Mn in Series A

MacroLux (Chinese: 星辰海) announced that it had completed a nearly CNY 100 million Series A funding round, which was led by Legend Capital (Chinese: 君联资本) and followed by Dalton Venture (Chinese: 道彤投资). After this financing, MacroLux will accelerate to provide more solutions that meet global clients’ needs. Founded in 2020, MacroLux is a medical technology company providing innovative solutions for interventional endoscopic therapy. Endoscopic therapies has become highly important in many diseases such as digestion disease, respiratory disease, and urology disease. Single-use electronic endoscope has higher efficiency, lower costs than traditional endoscope, and can avoid cross infection. So MacroLux is dedicated to the product development and technology innovation of single-use endoscope.

Healthcare

LEARN MORE

robots

In-depth

Technology Interview With TI5 ROBOT: The Rise of the Robot Industry

Huang Yuanpu

In-depth

Communication Yuanpu Huang: The Great Opportunity for Chinese Brands to Go Global under Bipolar Pattern